---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/41474844.md"
description: "Brain Regeneration Technology rose by two to three points, Intuitive Surgical edged up slightly; the medical device and small-cap biotech sectors showed some independent momentum. Pfizer was basically flat, while Hengrui Medicine and Kangfang Biotech both fell by two to three points. The innovative drug sector as a whole was relatively weak😔On days when the broader market is volatile, the pharmaceutical sector is also stratified: surgical robots and small-cap stocks with clinical catalysts each have their own stories, while traditional pharma companies and Hong Kong-listed innovative drug stocks are still waiting for the outcome of medical insurance negotiations and data releases. Without catalysts, they can only drift along with the broader market."
datetime: "2026-06-04T10:47:24.000Z"
locales:
  - [en](https://longbridge.com/en/topics/41474844.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/41474844.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/41474844.md)
author: "[人间半盏茶](https://longbridge.com/en/profiles/26892850.md)"
---

# Brain Regeneration Technology rose by two to three…


### Related Stocks

- [RGC.US](https://longbridge.com/en/quote/RGC.US.md)
- [ISRG.US](https://longbridge.com/en/quote/ISRG.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [600276.CN](https://longbridge.com/en/quote/600276.CN.md)
- [01276.HK](https://longbridge.com/en/quote/01276.HK.md)
- [09926.HK](https://longbridge.com/en/quote/09926.HK.md)